Global and United States Transdermal Skin Patch Market Insights, Forecast to 2026

Publisher Name :
Date: 04-Sep-2020
No. of pages: 142
Inquire Before Buying

Transdermal Skin Patch market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Transdermal Skin Patch market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Transdermal Skin Patch market is segmented into

- Fentanyl Transdermal Skin Patch

- Nicotine Transdermal Skin Patch

- Clonidine Transdermal Skin Patch

- Buprenorphine Transdermal Skin Patch

Segment by Application, the Transdermal Skin Patch market is segmented into

- Relieve Severe Pain

- Stop Smoking Cigarettes

- Treat An Overactive Bladder

- Others

Regional and Country-level Analysis

The Transdermal Skin Patch market is analysed and market size information is provided by regions (countries).

The key regions covered in the Transdermal Skin Patch market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Transdermal Skin Patch Market Share Analysis

Transdermal Skin Patch market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Transdermal Skin Patch business, the date to enter into the Transdermal Skin Patch market, Transdermal Skin Patch product introduction, recent developments, etc.

The major vendors covered:

- Hisamitsu Pharmaceutical

- Novartis

- Johnson & Johnson

- Teikoku Pharma

- Mylan

- Actavis

- Mundipharma

- Henan Lingrui Pharmaceutical

- Changzhou Siyao

- Rfl Pharmaceutical

- Luye Pharma Group Ltd.

- Purdue Pharma L.P.

- Teva Pharmaceutical Industries Ltd.

Global and United States Transdermal Skin Patch Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Transdermal Skin Patch Product Introduction
1.2 Market Segments
1.3 Key Transdermal Skin Patch Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Transdermal Skin Patch Market Size Growth Rate by Type
1.4.2 Fentanyl Transdermal Skin Patch
1.4.3 Nicotine Transdermal Skin Patch
1.4.4 Clonidine Transdermal Skin Patch
1.4.5 Buprenorphine Transdermal Skin Patch
1.5 Market by Application
1.5.1 Global Transdermal Skin Patch Market Size Growth Rate by Application
1.5.2 Relieve Severe Pain
1.5.3 Stop Smoking Cigarettes
1.5.4 Treat An Overactive Bladder
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Transdermal Skin Patch Market Size, Estimates and Forecasts
2.1.1 Global Transdermal Skin Patch Revenue 2015-2026
2.1.2 Global Transdermal Skin Patch Sales 2015-2026
2.2 Global Transdermal Skin Patch, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Transdermal Skin Patch Historical Market Size by Region (2015-2020)
2.3.1 Global Transdermal Skin Patch Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Transdermal Skin Patch Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Transdermal Skin Patch Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Transdermal Skin Patch Sales Forecast by Region (2021-2026)
2.4.2 Global Transdermal Skin Patch Revenue Forecast by Region (2021-2026)
3 Global Transdermal Skin Patch Competitor Landscape by Players
3.1 Global Top Transdermal Skin Patch Sales by Manufacturers
3.1.1 Global Transdermal Skin Patch Sales by Manufacturers (2015-2020)
3.1.2 Global Transdermal Skin Patch Sales Market Share by Manufacturers (2015-2020)
3.2 Global Transdermal Skin Patch Manufacturers by Revenue
3.2.1 Global Transdermal Skin Patch Revenue by Manufacturers (2015-2020)
3.2.2 Global Transdermal Skin Patch Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Transdermal Skin Patch Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Transdermal Skin Patch Revenue in 2019
3.2.5 Global Transdermal Skin Patch Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Transdermal Skin Patch Price by Manufacturers
3.4 Global Transdermal Skin Patch Manufacturing Base Distribution, Product Types
3.4.1 Transdermal Skin Patch Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Transdermal Skin Patch Product Type
3.4.3 Date of International Manufacturers Enter into Transdermal Skin Patch Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Transdermal Skin Patch Market Size by Type (2015-2020)
4.1.1 Global Transdermal Skin Patch Sales by Type (2015-2020)
4.1.2 Global Transdermal Skin Patch Revenue by Type (2015-2020)
4.1.3 Transdermal Skin Patch Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Transdermal Skin Patch Market Size Forecast by Type (2021-2026)
4.2.1 Global Transdermal Skin Patch Sales Forecast by Type (2021-2026)
4.2.2 Global Transdermal Skin Patch Revenue Forecast by Type (2021-2026)
4.2.3 Transdermal Skin Patch Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Transdermal Skin Patch Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Transdermal Skin Patch Market Size by Application (2015-2020)
5.1.1 Global Transdermal Skin Patch Sales by Application (2015-2020)
5.1.2 Global Transdermal Skin Patch Revenue by Application (2015-2020)
5.1.3 Transdermal Skin Patch Price by Application (2015-2020)
5.2 Transdermal Skin Patch Market Size Forecast by Application (2021-2026)
5.2.1 Global Transdermal Skin Patch Sales Forecast by Application (2021-2026)
5.2.2 Global Transdermal Skin Patch Revenue Forecast by Application (2021-2026)
5.2.3 Global Transdermal Skin Patch Price Forecast by Application (2021-2026)
6 United States by Players, Type and Application
6.1 United States Transdermal Skin Patch Market Size YoY Growth 2015-2026
6.1.1 United States Transdermal Skin Patch Sales YoY Growth 2015-2026
6.1.2 United States Transdermal Skin Patch Revenue YoY Growth 2015-2026
6.1.3 United States Transdermal Skin Patch Market Share in Global Market 2015-2026
6.2 United States Transdermal Skin Patch Market Size by Players (International and Local Players)
6.2.1 United States Top Transdermal Skin Patch Players by Sales (2015-2020)
6.2.2 United States Top Transdermal Skin Patch Players by Revenue (2015-2020)
6.3 United States Transdermal Skin Patch Historic Market Review by Type (2015-2020)
6.3.1 United States Transdermal Skin Patch Sales Market Share by Type (2015-2020)
6.3.2 United States Transdermal Skin Patch Revenue Market Share by Type (2015-2020)
6.3.3 United States Transdermal Skin Patch Price by Type (2015-2020)
6.4 United States Transdermal Skin Patch Market Estimates and Forecasts by Type (2021-2026)
6.4.1 United States Transdermal Skin Patch Sales Forecast by Type (2021-2026)
6.4.2 United States Transdermal Skin Patch Revenue Forecast by Type (2021-2026)
6.4.3 United States Transdermal Skin Patch Price Forecast by Type (2021-2026)
6.5 United States Transdermal Skin Patch Historic Market Review by Application (2015-2020)
6.5.1 United States Transdermal Skin Patch Sales Market Share by Application (2015-2020)
6.5.2 United States Transdermal Skin Patch Revenue Market Share by Application (2015-2020)
6.5.3 United States Transdermal Skin Patch Price by Application (2015-2020)
6.6 United States Transdermal Skin Patch Market Estimates and Forecasts by Application (2021-2026)
6.6.1 United States Transdermal Skin Patch Sales Forecast by Application (2021-2026)
6.6.2 United States Transdermal Skin Patch Revenue Forecast by Application (2021-2026)
6.6.3 United States Transdermal Skin Patch Price Forecast by Application (2021-2026)
7 North America
7.1 North America Transdermal Skin Patch Market Size YoY Growth 2015-2026
7.2 North America Transdermal Skin Patch Market Facts & Figures by Country
7.2.1 North America Transdermal Skin Patch Sales by Country (2015-2020)
7.2.2 North America Transdermal Skin Patch Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Transdermal Skin Patch Market Size YoY Growth 2015-2026
8.2 Europe Transdermal Skin Patch Market Facts & Figures by Country
8.2.1 Europe Transdermal Skin Patch Sales by Country
8.2.2 Europe Transdermal Skin Patch Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Transdermal Skin Patch Market Size YoY Growth 2015-2026
9.2 Asia Pacific Transdermal Skin Patch Market Facts & Figures by Country
9.2.1 Asia Pacific Transdermal Skin Patch Sales by Region (2015-2020)
9.2.2 Asia Pacific Transdermal Skin Patch Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Transdermal Skin Patch Market Size YoY Growth 2015-2026
10.2 Latin America Transdermal Skin Patch Market Facts & Figures by Country
10.2.1 Latin America Transdermal Skin Patch Sales by Country
10.2.2 Latin America Transdermal Skin Patch Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Transdermal Skin Patch Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Transdermal Skin Patch Market Facts & Figures by Country
11.2.1 Middle East and Africa Transdermal Skin Patch Sales by Country
11.2.2 Middle East and Africa Transdermal Skin Patch Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Hisamitsu Pharmaceutical
12.1.1 Hisamitsu Pharmaceutical Corporation Information
12.1.2 Hisamitsu Pharmaceutical Description and Business Overview
12.1.3 Hisamitsu Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Hisamitsu Pharmaceutical Transdermal Skin Patch Products Offered
12.1.5 Hisamitsu Pharmaceutical Recent Development
12.2 Novartis
12.2.1 Novartis Corporation Information
12.2.2 Novartis Description and Business Overview
12.2.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Novartis Transdermal Skin Patch Products Offered
12.2.5 Novartis Recent Development
12.3 Johnson & Johnson
12.3.1 Johnson & Johnson Corporation Information
12.3.2 Johnson & Johnson Description and Business Overview
12.3.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Johnson & Johnson Transdermal Skin Patch Products Offered
12.3.5 Johnson & Johnson Recent Development
12.4 Teikoku Pharma
12.4.1 Teikoku Pharma Corporation Information
12.4.2 Teikoku Pharma Description and Business Overview
12.4.3 Teikoku Pharma Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Teikoku Pharma Transdermal Skin Patch Products Offered
12.4.5 Teikoku Pharma Recent Development
12.5 Mylan
12.5.1 Mylan Corporation Information
12.5.2 Mylan Description and Business Overview
12.5.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Mylan Transdermal Skin Patch Products Offered
12.5.5 Mylan Recent Development
12.6 Actavis
12.6.1 Actavis Corporation Information
12.6.2 Actavis Description and Business Overview
12.6.3 Actavis Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Actavis Transdermal Skin Patch Products Offered
12.6.5 Actavis Recent Development
12.7 Mundipharma
12.7.1 Mundipharma Corporation Information
12.7.2 Mundipharma Description and Business Overview
12.7.3 Mundipharma Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Mundipharma Transdermal Skin Patch Products Offered
12.7.5 Mundipharma Recent Development
12.8 Henan Lingrui Pharmaceutical
12.8.1 Henan Lingrui Pharmaceutical Corporation Information
12.8.2 Henan Lingrui Pharmaceutical Description and Business Overview
12.8.3 Henan Lingrui Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Henan Lingrui Pharmaceutical Transdermal Skin Patch Products Offered
12.8.5 Henan Lingrui Pharmaceutical Recent Development
12.9 Changzhou Siyao
12.9.1 Changzhou Siyao Corporation Information
12.9.2 Changzhou Siyao Description and Business Overview
12.9.3 Changzhou Siyao Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Changzhou Siyao Transdermal Skin Patch Products Offered
12.9.5 Changzhou Siyao Recent Development
12.10 Rfl Pharmaceutical
12.10.1 Rfl Pharmaceutical Corporation Information
12.10.2 Rfl Pharmaceutical Description and Business Overview
12.10.3 Rfl Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Rfl Pharmaceutical Transdermal Skin Patch Products Offered
12.10.5 Rfl Pharmaceutical Recent Development
12.11 Hisamitsu Pharmaceutical
12.11.1 Hisamitsu Pharmaceutical Corporation Information
12.11.2 Hisamitsu Pharmaceutical Description and Business Overview
12.11.3 Hisamitsu Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Hisamitsu Pharmaceutical Transdermal Skin Patch Products Offered
12.11.5 Hisamitsu Pharmaceutical Recent Development
12.12 Purdue Pharma L.P.
12.12.1 Purdue Pharma L.P. Corporation Information
12.12.2 Purdue Pharma L.P. Description and Business Overview
12.12.3 Purdue Pharma L.P. Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Purdue Pharma L.P. Products Offered
12.12.5 Purdue Pharma L.P. Recent Development
12.13 Teva Pharmaceutical Industries Ltd.
12.13.1 Teva Pharmaceutical Industries Ltd. Corporation Information
12.13.2 Teva Pharmaceutical Industries Ltd. Description and Business Overview
12.13.3 Teva Pharmaceutical Industries Ltd. Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Teva Pharmaceutical Industries Ltd. Products Offered
12.13.5 Teva Pharmaceutical Industries Ltd. Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Transdermal Skin Patch Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Transdermal Skin Patch Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Transdermal Skin Patch Market Segments
Table 2. Ranking of Global Top Transdermal Skin Patch Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Transdermal Skin Patch Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Fentanyl Transdermal Skin Patch
Table 5. Major Manufacturers of Nicotine Transdermal Skin Patch
Table 6. Major Manufacturers of Clonidine Transdermal Skin Patch
Table 7. Major Manufacturers of Buprenorphine Transdermal Skin Patch
Table 8. Global Transdermal Skin Patch Market Size Growth Rate by Application 2020-2026 (K Units)
Table 9. Global Transdermal Skin Patch Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 10. Global Transdermal Skin Patch Sales by Regions 2015-2020 (K Units)
Table 11. Global Transdermal Skin Patch Sales Market Share by Regions (2015-2020)
Table 12. Global Transdermal Skin Patch Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Transdermal Skin Patch Sales Forecast by Region (2021-2026) (K Units)
Table 14. Global Transdermal Skin Patch Sales by Manufacturers (2015-2020) (K Units)
Table 15. Global Transdermal Skin Patch Sales Share by Manufacturers (2015-2020)
Table 16. Global Transdermal Skin Patch Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Transdermal Skin Patch by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transdermal Skin Patch as of 2019)
Table 18. Transdermal Skin Patch Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Transdermal Skin Patch Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Transdermal Skin Patch Price (2015-2020) (USD/Unit)
Table 21. Transdermal Skin Patch Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Transdermal Skin Patch Product Type
Table 23. Date of International Manufacturers Enter into Transdermal Skin Patch Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Transdermal Skin Patch Sales by Type (2015-2020) (K Units)
Table 26. Global Transdermal Skin Patch Sales Share by Type (2015-2020)
Table 27. Global Transdermal Skin Patch Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Transdermal Skin Patch Revenue Share by Type (2015-2020)
Table 29. Transdermal Skin Patch Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 30. Global Transdermal Skin Patch Sales Share by Type (2021-2026)
Table 31. Global Transdermal Skin Patch Sales by Application (2015-2020) (K Units)
Table 32. Global Transdermal Skin Patch Sales Share by Application (2015-2020)
Table 33. Global Transdermal Skin Patch Sales Share by Application (2021-2026)
Table 34. Global Transdermal Skin Patch Sales Market Share Forecast by Application (2021-2026)
Table 35. Global Transdermal Skin Patch Revenue by Application (2015-2020) (US$ Million)
Table 36. Global Transdermal Skin Patch Revenue Market Share Forecast by Application (2021-2026)
Table 37. United States Transdermal Skin Patch Sales (K Units) of Key Companies (2015-2020)
Table 38. United States Transdermal Skin Patch Sales Share by Company (2015-2020)
Table 39. United States Transdermal Skin Patch Revenue (US$ Million) by Company (2015-2020)
Table 40. United States Transdermal Skin Patch Sales (K Units) by Type (2015-2020)
Table 41. United States Transdermal Skin Patch Sales Share by Type (2015-2020)
Table 42. United States Transdermal Skin Patch Revenue (US$ Million) Market Share by Type (2015-2020)
Table 43. United States Transdermal Skin Patch Price (K Units) by Type (2015-2020)
Table 44. United States Transdermal Skin Patch Sales (K Units) by Type (2021-2026)
Table 45. United States Transdermal Skin Patch Sales Share by Type (2021-2026)
Table 46. United States Transdermal Skin Patch Revenue (US$ Million) Market Share by Type (2021-2026)
Table 47. United States Transdermal Skin Patch Revenue Share by Type (2021-2026)
Table 48. United States Transdermal Skin Patch Price (K Units) by Type (2021-2026)
Table 49. United States Transdermal Skin Patch Sales (K Units) by Application (2015-2020)
Table 50. United States Transdermal Skin Patch Sales Share by Application (2015-2020)
Table 51. United States Transdermal Skin Patch Revenue (US$ Million) Market Share by Application (2015-2020)
Table 52. United States Transdermal Skin Patch Sales (K Units) by Application (2021-2026)
Table 53. United States Transdermal Skin Patch Sales Share by Application (2021-2026)
Table 54. United States Transdermal Skin Patch Revenue (US$ Million) Market Share by Application (2021-2026)
Table 55. United States Transdermal Skin Patch Revenue Share by Application (2021-2026)
Table 56. North America Transdermal Skin Patch Sales by Country (2015-2020) (K Units)
Table 57. North America Transdermal Skin Patch Sales Market Share by Country (2015-2020)
Table 58. North America Transdermal Skin Patch Revenue by Country (2015-2020) (US$ Million)
Table 59. North America Transdermal Skin Patch Revenue Market Share by Country (2015-2020)
Table 60. Europe Transdermal Skin Patch Sales by Country (2015-2020) (K Units)
Table 61. Europe Transdermal Skin Patch Sales Market Share by Country (2015-2020)
Table 62. Europe Transdermal Skin Patch Revenue by Country (2015-2020) (US$ Million)
Table 63. Europe Transdermal Skin Patch Revenue Market Share by Country (2015-2020)
Table 64. Asia Pacific Transdermal Skin Patch Sales by Region (2015-2020) (K Units)
Table 65. Asia Pacific Transdermal Skin Patch Sales Market Share by Region (2015-2020)
Table 66. Asia Pacific Transdermal Skin Patch Revenue by Region (2015-2020) (US$ Million)
Table 67. Asia Pacific Transdermal Skin Patch Revenue Market Share by Region (2015-2020)
Table 68. Latin America Transdermal Skin Patch Sales by Country (2015-2020) (K Units)
Table 69. Latin America Transdermal Skin Patch Sales Market Share by Country (2015-2020)
Table 70. Latin Americaa Transdermal Skin Patch Revenue by Country (2015-2020) (US$ Million)
Table 71. Latin America Transdermal Skin Patch Revenue Market Share by Country (2015-2020)
Table 72. Middle East and Africa Transdermal Skin Patch Sales by Country (2015-2020) (K Units)
Table 73. Middle East and Africa Transdermal Skin Patch Sales Market Share by Country (2015-2020)
Table 74. Middle East and Africa Transdermal Skin Patch Revenue by Country (2015-2020) (US$ Million)
Table 75. Middle East and Africa Transdermal Skin Patch Revenue Market Share by Country (2015-2020)
Table 76. Hisamitsu Pharmaceutical Corporation Information
Table 77. Hisamitsu Pharmaceutical Description and Business Overview
Table 78. Hisamitsu Pharmaceutical Transdermal Skin Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 79. Hisamitsu Pharmaceutical Transdermal Skin Patch Product
Table 80. Hisamitsu Pharmaceutical Recent Development
Table 81. Novartis Corporation Information
Table 82. Novartis Description and Business Overview
Table 83. Novartis Transdermal Skin Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 84. Novartis Product
Table 85. Novartis Recent Development
Table 86. Johnson & Johnson Corporation Information
Table 87. Johnson & Johnson Description and Business Overview
Table 88. Johnson & Johnson Transdermal Skin Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 89. Johnson & Johnson Product
Table 90. Johnson & Johnson Recent Development
Table 91. Teikoku Pharma Corporation Information
Table 92. Teikoku Pharma Description and Business Overview
Table 93. Teikoku Pharma Transdermal Skin Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 94. Teikoku Pharma Product
Table 95. Teikoku Pharma Recent Development
Table 96. Mylan Corporation Information
Table 97. Mylan Description and Business Overview
Table 98. Mylan Transdermal Skin Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 99. Mylan Product
Table 100. Mylan Recent Development
Table 101. Actavis Corporation Information
Table 102. Actavis Description and Business Overview
Table 103. Actavis Transdermal Skin Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 104. Actavis Product
Table 105. Actavis Recent Development
Table 106. Mundipharma Corporation Information
Table 107. Mundipharma Description and Business Overview
Table 108. Mundipharma Transdermal Skin Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 109. Mundipharma Product
Table 110. Mundipharma Recent Development
Table 111. Henan Lingrui Pharmaceutical Corporation Information
Table 112. Henan Lingrui Pharmaceutical Description and Business Overview
Table 113. Henan Lingrui Pharmaceutical Transdermal Skin Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 114. Henan Lingrui Pharmaceutical Product
Table 115. Henan Lingrui Pharmaceutical Recent Development
Table 116. Changzhou Siyao Corporation Information
Table 117. Changzhou Siyao Description and Business Overview
Table 118. Changzhou Siyao Transdermal Skin Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 119. Changzhou Siyao Product
Table 120. Changzhou Siyao Recent Development
Table 121. Rfl Pharmaceutical Corporation Information
Table 122. Rfl Pharmaceutical Description and Business Overview
Table 123. Rfl Pharmaceutical Transdermal Skin Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 124. Rfl Pharmaceutical Product
Table 125. Rfl Pharmaceutical Recent Development
Table 126. Luye Pharma Group Ltd. Corporation Information
Table 127. Luye Pharma Group Ltd. Description and Business Overview
Table 128. Luye Pharma Group Ltd. Transdermal Skin Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 129. Luye Pharma Group Ltd. Product
Table 130. Luye Pharma Group Ltd. Recent Development
Table 131. Purdue Pharma L.P. Corporation Information
Table 132. Purdue Pharma L.P. Description and Business Overview
Table 133. Purdue Pharma L.P. Transdermal Skin Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 134. Purdue Pharma L.P. Product
Table 135. Purdue Pharma L.P. Recent Development
Table 136. Teva Pharmaceutical Industries Ltd. Corporation Information
Table 137. Teva Pharmaceutical Industries Ltd. Description and Business Overview
Table 138. Teva Pharmaceutical Industries Ltd. Transdermal Skin Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 139. Teva Pharmaceutical Industries Ltd. Product
Table 140. Teva Pharmaceutical Industries Ltd. Recent Development
Table 141. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 142. Key Challenges
Table 143. Market Risks
Table 144. Main Points Interviewed from Key Transdermal Skin Patch Players
Table 145. Transdermal Skin Patch Customers List
Table 146. Transdermal Skin Patch Distributors List
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Transdermal Skin Patch Product Picture
Figure 2. Global Transdermal Skin Patch Sales Market Share by Type in 2020 & 2026
Figure 3. Fentanyl Transdermal Skin Patch Product Picture
Figure 4. Nicotine Transdermal Skin Patch Product Picture
Figure 5. Clonidine Transdermal Skin Patch Product Picture
Figure 6. Buprenorphine Transdermal Skin Patch Product Picture
Figure 7. Global Transdermal Skin Patch Sales Market Share by Application in 2020 & 2026
Figure 8. Relieve Severe Pain
Figure 9. Stop Smoking Cigarettes
Figure 10. Treat An Overactive Bladder
Figure 11. Others
Figure 12. Transdermal Skin Patch Report Years Considered
Figure 13. Global Transdermal Skin Patch Market Size 2015-2026 (US$ Million)
Figure 14. Global Transdermal Skin Patch Sales 2015-2026 (K Units)
Figure 15. Global Transdermal Skin Patch Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Transdermal Skin Patch Sales Market Share by Region (2015-2020)
Figure 17. Global Transdermal Skin Patch Sales Market Share by Region in 2019
Figure 18. Global Transdermal Skin Patch Revenue Market Share by Region (2015-2020)
Figure 19. Global Transdermal Skin Patch Revenue Market Share by Region in 2019
Figure 20. Global Transdermal Skin Patch Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Transdermal Skin Patch Revenue in 2019
Figure 22. Transdermal Skin Patch Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Transdermal Skin Patch Sales Market Share by Type (2015-2020)
Figure 24. Global Transdermal Skin Patch Sales Market Share by Type in 2019
Figure 25. Global Transdermal Skin Patch Revenue Market Share by Type (2015-2020)
Figure 26. Global Transdermal Skin Patch Revenue Market Share by Type in 2019
Figure 27. Global Transdermal Skin Patch Market Share by Price Range (2015-2020)
Figure 28. Global Transdermal Skin Patch Sales Market Share by Application (2015-2020)
Figure 29. Global Transdermal Skin Patch Sales Market Share by Application in 2019
Figure 30. Global Transdermal Skin Patch Revenue Market Share by Application (2015-2020)
Figure 31. Global Transdermal Skin Patch Revenue Market Share by Application in 2019
Figure 32. United States Transdermal Skin Patch Sales Growth Rate 2015-2026 (K Units)
Figure 33. United States Transdermal Skin Patch Revenue Growth Rate 2015-2026 (US$ Million)
Figure 34. United States Transdermal Skin Patch Market Share in Global Market 2015-2026
Figure 35. United States 5 and 10 Largest Transdermal Skin Patch Players Market Share by Revenue in Transdermal Skin Patch in 2019
Figure 36. United States Transdermal Skin Patch Revenue Share by Type (2015-2020)
Figure 37. United States Transdermal Skin Patch Revenue Growth Rate by Type in 2015 & 2019
Figure 38. United States Transdermal Skin Patch Revenue Share by Application (2015-2020)
Figure 39. United States Transdermal Skin Patch Revenue Growth Rate by Application in 2015 & 2019
Figure 40. North America Transdermal Skin Patch Sales Growth Rate 2015-2020 (K Units)
Figure 41. North America Transdermal Skin Patch Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. North America Transdermal Skin Patch Sales Market Share by Country in 2019
Figure 43. North America Transdermal Skin Patch Revenue Market Share by Country in 2019
Figure 44. U.S. Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)
Figure 45. U.S. Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. Canada Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)
Figure 47. Canada Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Europe Transdermal Skin Patch Sales Growth Rate 2015-2020 (K Units)
Figure 49. Europe Transdermal Skin Patch Revenue Growth Rate 2015-2020 (US$ Million)
Figure 50. Europe Transdermal Skin Patch Sales Market Share by Country in 2019
Figure 51. Europe Transdermal Skin Patch Revenue Market Share by Country in 2019
Figure 52. Germany Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)
Figure 53. Germany Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. France Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)
Figure 55. France Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. U.K. Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)
Figure 57. U.K. Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Italy Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)
Figure 59. Italy Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Russia Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)
Figure 61. Russia Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Asia Pacific Transdermal Skin Patch Sales Growth Rate 2015-2020 (K Units)
Figure 63. Asia Pacific Transdermal Skin Patch Revenue Growth Rate 2015-2020 (US$ Million)
Figure 64. Asia Pacific Transdermal Skin Patch Sales Market Share by Region in 2019
Figure 65. Asia Pacific Transdermal Skin Patch Revenue Market Share by Region in 2019
Figure 66. China Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)
Figure 67. China Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Japan Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)
Figure 69. Japan Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. South Korea Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)
Figure 71. South Korea Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. India Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)
Figure 73. India Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Australia Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)
Figure 75. Australia Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Taiwan Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)
Figure 77. Taiwan Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Indonesia Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)
Figure 79. Indonesia Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Thailand Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)
Figure 81. Thailand Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Malaysia Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)
Figure 83. Malaysia Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Philippines Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)
Figure 85. Philippines Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Vietnam Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)
Figure 87. Vietnam Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Latin America Transdermal Skin Patch Sales Growth Rate 2015-2020 (K Units)
Figure 89. Latin America Transdermal Skin Patch Revenue Growth Rate 2015-2020 (US$ Million)
Figure 90. Latin America Transdermal Skin Patch Sales Market Share by Country in 2019
Figure 91. Latin America Transdermal Skin Patch Revenue Market Share by Country in 2019
Figure 92. Mexico Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)
Figure 93. Mexico T
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs